Literature DB >> 17639231

Cutting-edge science and the future of tuberculosis control.

Roland Brosch1, Véronique Vincent.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17639231      PMCID： PMC2636641          DOI： 10.2471/06.035386

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  4 in total

1.  Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis.

Authors:  Ujjini H Manjunatha; Helena Boshoff; Cynthia S Dowd; Liang Zhang; Thomas J Albert; Jason E Norton; Lacy Daniels; Thomas Dick; Siew Siew Pang; Clifton E Barry
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-30       Impact factor: 11.205

2.  Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. Evidence that all strains synthesize glycosylated p-hydroxybenzoic methyl esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene.

Authors:  Patricia Constant; Esther Perez; Wladimir Malaga; Marie-Antoinette Lanéelle; Olivier Saurel; Mamadou Daffé; Christophe Guilhot
Journal:  J Biol Chem       Date:  2002-07-22       Impact factor: 5.157

3.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

4.  Genes required for mycobacterial growth defined by high density mutagenesis.

Authors:  Christopher M Sassetti; Dana H Boyd; Eric J Rubin
Journal:  Mol Microbiol       Date:  2003-04       Impact factor: 3.501
  4 in total
  2 in total

1.  Synthetic lipopeptide MALP-2 inhibits intracellular growth of Mycobacterium bovis BCG in alveolar macrophages-preliminary data.

Authors:  Grit Jörgens; Franz-Christoph Bange; Peter F Mühlradt; Reinhard Pabst; Ulrich A Maus; Thomas Tschernig
Journal:  Inflammation       Date:  2009-08       Impact factor: 4.092

2.  Implications of the impact of prevalence on test thresholds and outcomes: lessons from tuberculosis.

Authors:  Tanya G K Bentley; Antonino Catanzaro; Theodore G Ganiats
Journal:  BMC Res Notes       Date:  2012-10-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.